MECHELEN, BELGIUM--(Marketwire -09/04/12)-
Mechelen, Belgium; 4 September 2012 - Galapagos NV (GLPGF) announcedtoday that it has received a transparency notification from Johnson &Johnson,pursuant to the Belgian transparency legislation (Belgian Act of 2 May2007 onthe disclosure of major shareholdings in issuers whose shares areadmitted totrading on a regulated market).
Galapagos received a transparency notification on 30 August 2012 fromJohnson &Johnson and Galapagos co-founders Tibotec-Virco Comm. VA ("Tibotec-Virco") andCrucell Holland B.V. ("Crucell"). Johnson & Johnson notified that, as aresultof its acquisition of Crucell on 22 February 2011, Johnson & Johnsonindirectlyheld 2,350,061 Galapagos shares through Tibotec-Virco and Crucell,whichrepresents 8.8% of the 26,577,554 Galapagos shares outstanding today. Thetotalnumber of Galapagos shares held by these entities under Johnson &Johnson'scontrol, i.e. Tibotec-Virco (1,113,964 shares) and Crucell (1,236,097shares),remains unchanged compared to previous notifications made by thesecompanies.
Galapagos (GLPGF) (GLPYY) is a mid-sizeclinical stagebiotechnology company specialized in the discovery and development ofsmallmolecule and antibody therapies with novel modes-of-action. TheCompany isprogressing GLPG0634, as well as one of the largest pipelines in biotech,withfour programs in development and over 30 discovery programs. TheGalapagosGroup has over 800 employees and operates facilities in six countries,withglobal headquarters in Mechelen, Belgium. More info at: www.glpg.com
This release may contain forward-looking statements, including,withoutlimitation, statements containing the words "believes,""anticipates,""expects," "intends," "plans," "seeks," "estimates," "may," "will,""could,""stands to," and "continues," as well as similar expressions. Suchforward-looking statements may involve known and unknown risks, uncertainties andotherfactors which might cause the actual results, financial condition,performanceor achievements of Galapagos, or industry results, to be materiallydifferentfrom any historic or future results, financial conditions,performance orachievements expressed or implied by such forward-looking statements.Giventhese uncertainties, the reader is advised not to place any unduereliance onsuch forward-looking statements. These forward-looking statements speakonly asof the date of publication of this document. Galapagos expresslydisclaims anyobligation to update any such forward-looking statements in thisdocument toreflect any change in its expectations with regard thereto or anychange inevents, conditions or circumstances on which any such statement is based,unlessrequired by law or regulation.
This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Galapagos NV via Thomson Reuters ONE[HUG#1638547]
Elizabeth Goodwin, Director Investor Relations
Tel: +31 6 2291 6240